XKEMQ.PK.

[metro]

adding 20% in pre  - that is 95% now in 2 days - time to take some profits today

[waxweazle]

Xechem Receives Orphan Drug Designation From The FDA For Its Anti-Sickling Drug 5-HMF
Tuesday June 6, 6:30 am ET

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--June 6, 2006--Xechem International, Inc. (OTC BB: XKEM - News) Xechem International announced today that it has received Orphan Drug designation from the U.S. Food and Drug Administration (FDA), Office of Orphan Drug Products Development, for the five-membered heterocyclic anti-sickling compound known as 5-HMF for the treatment of patients suffering from sickle cell disease (SCD).

ADVERTISEMENT
Research led by Dr. Donald Abraham of Virginia Commonwealth University (VCU) has shown 5-HMF to be "the best potential anti-sickling agent in 30 years of sickle cell research", performed by his group. 5-HMF not only is a natural product with very little, if any, toxicity, but it has a high affinity for sickle cell hemoglobin. It is also very active in genetically modified mice as shown by Dr. Toshio Asakura, Director, and his colleagues at the NIH-NHLBI Sickle Cell Disease Reference Laboratory at the Children's Hospital of Philadelphia, University of Pennsylvania.

According to Xechem's Chairman and CEO, Dr. Ramesh Pandey, "We are pleased with the FDA's decision granting Orphan Drug Designation to 5-HMF. This puts Xechem into a unique position where the company will have two drugs in the pipeline for treating patients with sickle cell disease. 5-HMF is a new type of drug that interacts specifically with intracellular hemoglobin without interacting with other proteins in the body. Today there are no non-toxic drugs available on the market to treat SCD. We are actively proceeding with our first drug (NICOSAN(TM)) in the hope of bringing it to the Nigerian market immediately following Nigerian regulatory approval. We are also preparing the Investigational New Drug (IND) application for 5-HMF for submission to the FDA in the coming months."

About Orphan Drug Designation

Orphan Drug status entitles a company to various incentives including the waiver of Regulatory Filing fees, access to potential grant funding for non-clinical and clinical research to generate required data for marketing approval, and seven years of marketing exclusivity for a designated drug once approved by the FDA. (Orphan diseases are generally defined as those afflicting less than 200,000 people in the US.)

About Sickle Cell Disease

Sickle cell disease is an inherited blood disorder caused by an abnormality in the hemoglobin molecule. Patients with this disease often produce stiff, abnormally shaped red blood cells that sometimes do not flow freely through blood vessels. This can create clogs in the vessels, which in turn cuts off the flow of normal hemoglobin and oxygen to parts of the body, and can cause severe painful attacks, damage to various organs, and shortened life span. In the US, there are approximately 70-80,000 patients suffering with sickle cell disease, many of whom suffer unpredictable painful crises several times a year lasting a few hours to a week or more. In Nigeria, more than 4 million persons have the disease. Worldwide, approximately 12 million are believed to suffer from this disease.

About Xechem

Xechem International, Inc. is a development stage biopharmaceutical company whose focus and resources are currently being primarily directed toward the development and commercial launch of NICOSAN(TM) (to be marketed as HEMOXIN(TM) in the United States and Europe), which has shown efficacy in the prophylaxis management of Sickle Cell Disease (SCD). In addition to NICOSAN(TM) and 5-HMF, Xechem is also working on anticancer, antiviral (including AIDS), antifungal, antimalarial and antibacterial products from natural sources, including microbial and marine organisms. Xechem's mission is to bring relief to the millions of people who suffer from these diseases. Its focus is on the development of phyto-pharmaceuticals (Natural Herbal Drugs) and other proprietary technologies, including those used in the treatment of orphan diseases.

Forward Looking Statements

This press release contains certain forward looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, which are intended to be covered by safe harbors created hereby. Such forward looking statements involve known and unknown risks and uncertainties.


Contact:

Xechem International, Inc.
Stephen Burg, 707-426-8855

Source: Xechem International, Inc.

[skooled]

this one's should have slow gains all week ... lots of coverage

[waxweazle]

wow hard accumulate at the evening!

[waxweazle]

Watch XKEM for a Chartbreakout above 3 cent at the close!
3 cent is the last resistance than blue Sky!


We have 3 storms coming together at the same time creating the perfect storm.... there are other things involved, such
as stock pick sites also that is adding to this scenario, plus the awaited news!!!!! 3 items creating the storm are
inverted head and shoulder pattern, golden cross(50dma crossing 200dma), and triple top breakout!!!! Just one of these things can cause a stock to burst forth, but with 3 we have created the perfect storm(triple threat)!!!Take alook

http://stockcharts.com/h-sc/ui?s=XKEM&p=D&yr=0&mn=7&dy=0&id=p49859949983&a=78137821&listNum=1

[Stocky2000]

in the last run....we had the same black candle....
Definition:

The Black Spinning Top is a single candlestick pattern. Its shape is a small black body with upper and lower shadows having a greater length than the body's length.

Recognition Criteria:

1. The real body of the pattern is black and small.
2. The upper and lower shadows are longer than the real body's length.

Explanation:
The market moves higher and then sharply lower, or vice versa. It then closes above the opening price creating a black body. This represents complete indecision between the bulls and the bears. The actual length of the shadows is not important. The small body relative to the shadows is what makes the spinning top.
Important Factors:

If a Black Spinning Top is observed after a long rally or long white candlestick, this implies weakness among the bulls and it is a warning about a potential change or interruption in trend.
If a Black Spinning Top is observed after a long decline or a long black candlestick, this implies weakness among the bears and it is a warning about a potential change or interruption in trend.

Like most other single candlestick patterns, the Black Spinning Top has low reliability. It reflects only one day's trading and can be interpreted both as a continuation and a reversal pattern. This pattern must be used with other candlesticks for a better and healthier confirmation of a trend.

[Ramsburg]

I don't know much about XKEM prospects, this stock seems to be highly speculative, etc... but I must say the chart is very impressive right now.

The volume is truly above normal for such a penny like this, a lot of short term traders are in and out for sure increasing the «real» volume, but even so, the volume is still suspicious... After Tuesday candlestick I was not expecting to watch XKEM breaking 0.030 again so soon. 

After looking to the long term chart with weekly candles, we have a better picture of both the volume and the 0.030 barrier:

Best regards,

[waxweazle]

Breakout above 3 cent 

[waxweazle]

[waxweazle]

"Nigeria Breaks New Grounds in Biotechnology
By Frances Ovia, 06.18.2006



Nigeria has broken new grounds in biotechnology with the production of a drug which effectively controls the sickle cell anemia.
The drug named NICOSAM would be officially launched on July 8 by the President, Chief Olusegun Obasanjo.
According to the Minister of Science and Technology, Prof. Turner Isoun, the drug would also be exported to other countries of the world.
According to Isoun, this would be the first time that Nigeria would be exporting a drug of such a calibre and in such a field to other nations.
Apart from NICOSAM, Isoun also stated that Nigeria is also using IT to create biodiversity. He disclosed that in Odi, Rivers State, the ministry is overseeing a process whereby 10 local farmers rear grasscutters.
He said he foresees a situation in the near future whereby grasscutter would be produced like fish or chicken.
"We are creating biodiversity," the minister said adding that initiatives such as this would provide Nigerians with more of their food needs.
Isoun, a former university teacher and editor of an international science journal, had estimated that in a matter of 15 years about half of the global economy would be based on bio-economy.
According to him, by the year 2020, any nation, which ignores its biotechnology development, may live to regret it.
"Nigeria is also endowed with enormous bioresources across its six main ecological zones (mangrove/swamp; rainforests; derived savannah; montane/plateau; savannah; and semi-arid). How do we use the new IT domain of Bioinformatics to drive the growth and development of modern Biotechnology in Nigeria? It is estimated that by 2020, 50 percent of the world economy will be bio-economy," he told a conference of IT professionals at the last conference of the Nigeria Computer Society (NCS).
Isoun also said that the Neem Tree (known locally as Dongoyaro) is being processed for many uses by researchers in the country.
It had been the view of the minister at a lecture a few years after he assumed office that "The first indication that neem was being used for medical treatment was about 4,500 years ago. All the plant parts of the Neem Tree from the apex to the root are of medical importance. Today, scientific research validates the traditional uses of Neem in both the maintenance of general health and skin care. Neem is clinically proven to be anti-bacterial, anti-fungal, anti-parasitic, analgesic and anti- inflammatory."
Biotechnology is the use of biological processes or living microorganisms in industrial production.
Before the assumption of office of Isoun as the Minister for Science and Technology, very little was known about Biotech in Nigeria. His tenure has witnessed the concentration of efforts in biotech research which had culminated in a number of pilot projects going on in several parts of the country.
Isoun had stated, while delivering a paper on "A Science Agenda from an African Perspective" at the World Summit on Sustainable Development that "Biotechnology provides technological methods for enhancing African history and endowment for improving and sustaining bioresources, including Indigenous plants used for medicinal purposes, for food and for other products of economy and social value. Biotechnology contributes to food security through increased and food crop production (improved seeds, bio-pesticides) and food processing and storage (e.g. gamma irradiation)."
Experts said that Biotechnology has great potential to address the pervasive poverty and food security problems of the developing world.
The main plank for pursuing the biotech agenda for the ministry is the National Biotechnology Policy and the establishment of the National Biotechnology Development Agency (NABDA) which the minister established with the approval of the Federal Executive Council to be responsible for achieving the mandates of the policy in the promotion, development and coordination of biotechnology activities in the country."

http://www.thisdayonline.com/nview.php?id=50861

[Lucas Scott]

She's gone parabolic!

[raspi]

What do you guys think? Could it be that this news about drug being produced in Nigeria is just a huge lie??

[Lucas Scott]

Wouldn't surprise me a bit. I make the assumption with all penny stocks that everything they say is a fabrication. I don't pay much attention to penny stock news or PR's for that reason, just the chart. I sold XKEM this afternoon. Good luck.

[Terliso]

A lot of good pennies over here

3 moving averages that i'm following 50SMA, 200SMA, 200EMA clustering together along with the price... breakout now!

90 percent chance you can make profit just by using the 3 Magics <-------Only in my opinion

[waxweazle]

Yes XKEM looks very nice !!
MACD Bullish nice Candles ..

With no news i think consolidations... can fall till 4 cent under 4 cent i will ad more...

Because this Charet looks very Strong